Mancini Marianna
SEC insider (Form 3/4/5 filer). CIK 0001838112. Chief Operating Officer at Viking Therapeutics, Inc. (VKTX). 16 reported Form 4/5 transactions since Sep 2024; latest on Jul 29, 2026. Located in SAN DIEGO, CA.
Companies Mancini Marianna has filed insider reports for
- Viking Therapeutics, Inc. (VKTX): Officer, Chief Operating Officer
Mancini Marianna
CIK: 0001838112
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Viking Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (16 total)
- Jul 29, 2026VKTX
Viking Therapeutics, Inc.
SaleDirect18.2K shares at avg. $33.47$610K - Jul 28, 2026VKTX
Viking Therapeutics, Inc.
AwardDirect31.7K shares- - Jan 5, 2026VKTX
Viking Therapeutics, Inc.
SaleDirect32K shares at avg. $32.29$1.0M - Jan 5, 2026VKTX
Viking Therapeutics, Inc.
SaleDirect13.6K shares at avg. $33.37$454K - Jan 5, 2026VKTX
Viking Therapeutics, Inc.
SaleDirect10.5K shares at avg. $34.22$359K - Jan 5, 2026VKTX
Viking Therapeutics, Inc.
SaleDirect1.6K shares at avg. $35.07$56K - Jan 2, 2026VKTX
Viking Therapeutics, Inc.
AwardDirect32K shares- - Jan 2, 2026VKTX
Viking Therapeutics, Inc.
AwardDirect41K shares- - Oct 28, 2025VKTX
Viking Therapeutics, Inc.
SaleDirect6.2K shares at avg. $35.00$216K - Oct 27, 2025VKTX
Viking Therapeutics, Inc.
AwardDirect11.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jul 29, 2026 | VKTX Viking Therapeutics, Inc. | Sale | 18,217 | $33.47 | $609,636 | Direct |
| Jul 28, 2026 | VKTX Viking Therapeutics, Inc. | Award | 31,667 | - | $0 | Direct |
| Jan 5, 2026 | VKTX Viking Therapeutics, Inc. | Sale | 31,961 | $32.29 | $1,032,110 | Direct |
| Jan 5, 2026 | VKTX Viking Therapeutics, Inc. | Sale | 13,600 | $33.37 | $453,876 | Direct |
| Jan 5, 2026 | VKTX Viking Therapeutics, Inc. | Sale | 10,500 | $34.22 | $359,303 | Direct |
| Jan 5, 2026 | VKTX Viking Therapeutics, Inc. | Sale | 1,600 | $35.07 | $56,117 | Direct |
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc. | Award | 32,049 | - | $0 | Direct |
| Jan 2, 2026 | VKTX Viking Therapeutics, Inc. | Award | 41,000 | - | $0 | Direct |
| Oct 28, 2025 | VKTX Viking Therapeutics, Inc. | Sale | 6,185 | $35.00 | $216,492 | Direct |
| Oct 27, 2025 | VKTX Viking Therapeutics, Inc. | Award | 11,117 | - | - | Direct |
1-10 of 16 transactions